Recent progress in analysis of intermediary metabolism by ex vivo 13 C NMR.
Craig R MalloyA Dean SherryJeffry R AlgerEunsook S JinPublished in: NMR in biomedicine (2022)
Advanced imaging technologies, large-scale metabolomics, and the measurement of gene transcripts or enzyme expression all enable investigations of intermediary metabolism in human patients. Complementary information about fluxes in individual metabolic pathways may be obtained by ex vivo 13 C NMR of blood or tissue biopsies. Simple molecules such as 13 C-labeled glucose are readily administered to patients prior to surgical biopsies, and 13 C-labeled glycerol is easily administered orally to outpatients. Here, we review recent progress in practical applications of 13 C NMR to study cancer biology, the response to oxidative stress, gluconeogenesis, triglyceride synthesis in patients, as well as new insights into compartmentation of metabolism in the cytosol. The technical aspects of obtaining the sample, preparing material for analysis, and acquiring the spectra are relatively simple. This approach enables convenient, valuable, and quantitative insights into intermediary metabolism in patients.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- oxidative stress
- high resolution
- magnetic resonance
- healthcare
- type diabetes
- mass spectrometry
- squamous cell carcinoma
- poor prognosis
- metabolic syndrome
- genome wide
- young adults
- signaling pathway
- blood pressure
- photodynamic therapy
- skeletal muscle
- ischemia reperfusion injury
- endoplasmic reticulum stress
- fluorescence imaging
- induced pluripotent stem cells